⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3231110 | 0.85 | MGAM (0.37) | — | |
| SCHEMBL3230121 | 0.85 | MGAM (0.37) | — | |
| SCHEMBL424737 | 0.85 | USP2 (0.33) | — | |
| SCHEMBL2803990 | 0.85 | USP2 (0.33) | — | |
| SCHEMBL3235094 | 0.85 | USP2 (0.33) | — | |
| SCHEMBL14734846 | 0.79 | — | — | |
| SCHEMBL3230568 | 0.77 | USP2 (0.39) | — | |
| SCHEMBL3227090 | 0.77 | USP2 (0.39) | — | |
| SCHEMBL3230013 | 0.75 | MGAM (0.30) | — | |
| SCHEMBL3238393 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105698-A1 | METHOD FOR PRODUCING COLLAGEN-CONTAINING STRUCTURE | ＴＯＰＰＡＮホールディングス株式会社 | 2026-05-21 | — | — | WO | disclosed |
| EP-3389674-A1 | CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING | Tega Therapeutics, Inc. (US) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017106782-A1 | CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING | TEGA THERAPEUTICS, INC. (US) | 2017-06-22 | — | — | WO | disclosed |
| US-8663716-B2 | Composition for treatment of aesthenopia | NIHON PHARMACEUTICAL CO., LTD. (JP) | 2014-03-04 | — | — | US | disclosed |
| US-20130052286-A1 | COMPOSITION FOR TREATMENT OF AESTHENOPIA | NIHON PHARMACEUTICAL CO., LTD (JP) | 2013-02-28 | — | — | US | disclosed |
| EP-1532438-A4 | OLIGOSACCHARIDE BIOMARKERS FOR MUCOPOLYSACCHARIDOSES AND OTHER RELATED DISORDERS | WOMENS & CHILDRENS HOSPITAL (AU) | 2006-12-06 | — | — | EP | disclosed |
| EP-1532438-A1 | OLIGOSACCHARIDE BIOMARKERS FOR MUCOPOLYSACCHARIDOSES AND OTHER RELATED DISORDERS | WOMEN'S AND CHILDREN'S HOSPITAL (AU) | 2005-05-25 | — | — | EP | disclosed |
| WO-2003106997-A1 | OLIGOSACCHARIDE BIOMARKERS FOR MUCOPOLYSACCHARIDOSES AND OTHER RELATED DISORDERS | WOMEN'S AND CHILDREN'S HOSPITAL (AU) | 2003-12-24 | — | — | WO | disclosed |